InvestorsHub Logo
Followers 7
Posts 1577
Boards Moderated 0
Alias Born 02/27/2014

Re: bajista post# 69981

Wednesday, 09/17/2014 12:25:50 PM

Wednesday, September 17, 2014 12:25:50 PM

Post# of 80868
Musclepharm is not gonna dilute the stock excessively going forward as it already has rewarded management and endorsers generously prior to the Nasdaq listing. Nasdaq listed companies cannot dilute their stock with 10% or more year over year...

Anyways, there is no need for it as MP becomes profitable....worry about excessive salaries going forward.